Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy for arterial thrombosis

G Vassalli1, D A Dichek

  • 1Gladstone Institute of Cardiovascular Disease, Department of Medicine, University of California, San Francisco 94141-9100, USA.

Cardiovascular Research
|January 31, 1998
PubMed
Summary

Gene therapy offers a promising new approach to prevent arterial thrombosis, avoiding systemic side effects. This method targets specific vessel wall sites with antithrombotic genes, showing potential in various clinical settings.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sphingolipid composition of circulating extracellular vesicles after myocardial ischemia.

Scientific reports·2020
Same author

Control of clot lysis by gene transfer.

Trends in cardiovascular medicine·2011
Same author

Construction of a novel expression cassette for increasing transgene expression in vivo in endothelial cells of large blood vessels.

Gene therapy·2010
Same author

Genetic selection system allowing monitoring of myofibrillogenesis in living cardiomyocytes derived from mouse embryonic stem cells.

European journal of histochemistry : EJH·2008
Same author

N-cadherin is essential for retinoic acid-mediated cardiomyogenic differentiation in mouse embryonic stem cells.

European journal of histochemistry : EJH·2007
Same author

Bone marrow stem cell therapy for cardiac repair: challenges and perspectives.

Minerva cardioangiologica·2007

Area of Science:

  • Vascular Biology
  • Gene Therapy
  • Thrombosis Research

Background:

  • Conventional antithrombotic drugs have limitations, including variable efficacy and hemorrhagic side effects.
  • Arterial thrombosis necessitates novel therapeutic strategies for prevention and treatment.
  • Gene transfer presents a targeted approach to express antithrombotic genes locally, minimizing systemic anticoagulation.

Purpose of the Study:

  • To explore the potential of gene therapy for preventing and treating arterial thrombosis.
  • To evaluate gene transfer methods for delivering antithrombotic genes to the arterial wall.
  • To identify clinical conditions where antithrombotic gene therapy could be beneficial.

Main Methods:

  • Direct in vivo gene transfer using viral vectors administered luminally.
  • In vitro genetic manipulation of cells for seeding onto vascular grafts, stents, or arteries.
  • Delivery of genes encoding prostacyclin pathway enzymes, nitric oxide synthase, hirudin, or thrombomodulin.
  • Overexpression of plasminogen activators in vascular grafts to enhance fibrinolytic activity.

Main Results:

  • Successful delivery of antithrombotic genes to animal arteries in vivo via direct gene transfer.
  • Demonstrated enhancement of vascular graft fibrinolytic activity through in vitro gene transfer.
  • Identified several antithrombotic genes suitable for therapeutic application.

Conclusions:

  • Gene therapy is a viable strategy for localized antithrombotic gene expression, addressing limitations of conventional treatments.
  • Both in vivo and in vitro gene transfer methods show promise for preventing and treating arterial thrombosis.
  • Further research and development of vectors for prolonged transgene expression are needed before human studies can commence.

Related Experiment Videos